In-situ polymerization-mediated glycan density measurement on…
A new blood test using microfluidic technology could help doctors diagnose acute myeloid leukemia more quickly and reliably by measuring specific markers on cancer-derived particles.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Quantum dot-DNA microsphere aptamer biosensor with AI-assisted…
Researchers combined AI-guided design with nanobiotechnology to create an affordable blood test that detects lung cancer with high accuracy, potentially accessible to more patients.
Underserved or high-risk populationsReal-world trends in diagnosis, treatment, and survival of non-small…
In Vietnam, lung cancer survival more than doubled over six years as doctors increasingly used genetic testing to prescribe targeted therapies, showing real-world gains in underserved regions.
Underserved or high-risk populationsAssociation of TP53 polymorphic variants rs1042522 and rs1642785 with…
This study helps fill a gap in understanding childhood leukemia genetics by examining gene variants in an understudied indigenous-admixed Brazilian population.
Promising but preliminaryAutologous tumor-immune effusion cocultures enable ex vivo functional…
A new lab platform lets doctors test how individual patients' tumors respond to combined radiation and immunotherapy, moving toward truly personalized cancer treatment planning.